Wall Street Journal, July 9, 2018 by Sumathi Reddy Efforts to bring a vaccine for Lyme disease to the market have run aground amid heated debate over the years. Now, a European company is in the early stages of creating a vaccine for the increasingly common tick-borne disease.... Read More »